I. Bilgetekin, B. Cetin, A. Ozet
{"title":"Antiangiogenic therapy in ovarian cancer – for whom and when?","authors":"I. Bilgetekin, B. Cetin, A. Ozet","doi":"10.15557/CGO.2017.0007","DOIUrl":null,"url":null,"abstract":"© Medical Communications Sp. z o.o. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (CC BY-NC-ND). Reproduction is permitted for personal, educational, non-commercial use, provided that the original article is in whole, unmodified, and properly cited. Antiangiogenic therapy in ovarian cancer – for whom and when? Terapia antyangiogenna w raku jajnika – dla kogo i kiedy?","PeriodicalId":38739,"journal":{"name":"Current Gynecologic Oncology","volume":"46 1","pages":"78-85"},"PeriodicalIF":0.0000,"publicationDate":"2017-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Gynecologic Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15557/CGO.2017.0007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2
抗血管生成治疗卵巢癌-对谁和何时?
©Medical Communications Sp. z .o.这是一篇基于知识共享署名-非商业性-非衍生品许可协议(CC BY-NC-ND)的开放获取文章。允许复制用于个人,教育,非商业用途,前提是原始文章是完整的,未经修改,并适当引用。抗血管生成治疗卵巢癌-对谁和何时?特拉皮亚抗黄疸病-黄疸病?
本文章由计算机程序翻译,如有差异,请以英文原文为准。